A large survey of Japanese men aged 50 and older, conducted in 2026, has quietly overturned one of medicine's oldest assumptions about male sexuality: that erection is what men value most. When asked which sexual function they would least want to lose in the face of prostate cancer treatment, nearly half chose arousal — the capacity to feel desire — over performance, fertility, or orgasm. The finding invites medicine to reconsider not just how it treats the aging male body, but how it understands what it means to remain sexually alive.
Sexual arousal trumps erection as older men's top priority, Japanese survey finds
Cobertura Relacionada
Earl Spencer tells BBC that press scrutiny of Harry and Meghan echoes the harmful treatment his sister Princess Diana fa…
The Guardian · Sep 20 Child killed in Blue Mountains stabbing; two children and woman criticalA child died and two other children and a woman were critically injured in a stabbing attack in a vehicle in NSW's Blue …
BBC News · Sep 20 Earl Spencer draws parallels between Diana's media treatment and Sussexes' scrutinyPrincess Diana's brother tells BBC that Harry and Meghan face similar media scrutiny to his sister, calling press covera…
dailynews.co.tz · Sep 20 Tanzania expands cardiac hub with 112bn/- China-backed JKCI facilityTanzania signed a 112 billion shilling agreement with China to expand the Jakaya Kikwete Cardiac Institute, doubling its…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
Japanese health survey on aging male sexuality has no geopolitical implications; it is a medical research study on quality-of-life priorities.
N/A - This is a domestic health research publication with no international relations, military, economic competition, or diplomatic dimensions.
Lente Econômica
Japanese survey of 6,000 older men reveals sexual arousal prioritized over erectile function, with implications for healthcare providers, pharmaceutical companies, and medical device manufacturers serving aging populations.
Older men may seek alternative treatments prioritizing arousal over erection alone, potentially shifting demand toward comprehensive sexual health solutions rather than single-function medications. This could increase healthcare spending on holistic sexual wellness treatments and consultations.
Healthcare systems may need to revise treatment guidelines and insurance coverage policies to address broader sexual function domains beyond erectile dysfunction. Regulatory bodies may require pharmaceutical companies to conduct more comprehensive sexual health outcome studies. Aging-focused healthcare policies should incorporate patient preference data into treatment decision-making frameworks.